EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology

Lorenzo Kiferle, Martina Giuntini, Ubaldo Bonuccelli, Roberto Ceravolo

Neurodegenerative Diseases · 2015 · 15 (5) · 271-280

DOI: 10.1159/000433438 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurodegenerative Diseases, online erschienen am 28.07.2015. Verfasst von Lorenzo Kiferle und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Department of Clinical and Experimental Neurology, University of Pisa, Pisa, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucocerebrosidase (GBA) mutations have been described as the most prevalent in Parkinson's disease (PD) and in Lewy body dementia, accounting for up to 7 and 13.8% of cases, respectively. To elucidate the pathophysiology of idiopathic Parkinson's disease (iPD), the pathogenic mechanisms leading to Lewy body accumulation in GBA-associated parkinsonism (GBA-PD) are a matter of current research. However, only few imaging studies, conducted on small GBA-PD patient cohorts, exist.

Methods

We provide an overview of current structural and functional imaging studies in patients with Gaucher's disease and parkinsonism and in GBA-PD patients, underlining the main differences compared to iPD.

Results

A limited number of PET studies have been conducted in GBA-PD, exploring brain metabolism and dopaminergic presynaptic and postsynaptic function. Moreover, structural MRI and spectroscopy studies recently evidenced the differences with iPD, aiding to understand of some peculiar aspects of iPD. Finally, new evidence from transcranial sonography confirms the technique's role in the study of GBA-PD and highlights the additional involvement of the raphe nucleus.

Conclusions

Further imaging studies conducted in a broader population of early GBA-PD are warranted to characterize the disease and elucidate the pathophysiological mechanisms underlying GBA-PD and to understand GBA implications in iPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainDopamineFemaleGaucher DiseaseGlucosylceramidaseHumansMagnetic Resonance ImagingMaleParkinsonian DisordersPositron-Emission TomographySynapsesUltrasonography, Doppler, Transcranial

Substanzen

GlucosylceramidaseDopamine

Autor:innen und Institutionen

  • Neurology Unit, Department of Clinical and Experimental Neurology, University of Pisa, Pisa, Italy.

Zitieren

APA

Kiferle, L., Giuntini, M., Bonuccelli, U., & Ceravolo, R. (2015). Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. Neurodegenerative Diseases, 15(5), 271-280. https://doi.org/10.1159/000433438

Vancouver

Kiferle L, Giuntini M, Bonuccelli U, Ceravolo R. Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. Neurodegenerative Diseases. 2015;15(5):271-280. doi:10.1159/000433438

BibTeX
@article{Kiferle2015,
  author = {Kiferle, Lorenzo and Giuntini, Martina and Bonuccelli, Ubaldo and Ceravolo, Roberto},
  title = {Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology},
  journal = {Neurodegenerative Diseases},
  year = {2015},
  volume = {15},
  number = {5},
  pages = {271--280},
  doi = {10.1159/000433438}
}
Kostenlos starten →